Swiss All Share Index
16 321,53
|
18,81
|
0,12 %
|
Analysen zu Swiss All Share Index-Werten
16.01.24 | DocMorris Add | Baader Bank | |
16.01.24 | DocMorris Buy | Jefferies & Company Inc. | |
16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
16.01.24 | Roche Hold | Jefferies & Company Inc. | |
16.01.24 | UBS Buy | Goldman Sachs Group Inc. | |
16.01.24 | DocMorris Sell | UBS AG | |
15.01.24 | Roche Neutral | UBS AG | |
15.01.24 | Novartis Buy | UBS AG | |
15.01.24 | UBS Kaufen | DZ BANK | |
15.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
15.01.24 | DocMorris Add | Baader Bank | |
15.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
15.01.24 | ABB Sector Perform | RBC Capital Markets | |
12.01.24 | Richemont Buy | Deutsche Bank AG | |
12.01.24 | Richemont Buy | Jefferies & Company Inc. | |
12.01.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
12.01.24 | Richemont Sector Perform | RBC Capital Markets | |
12.01.24 | ams-OSRAM Outperform | Bernstein Research | |
11.01.24 | UBS Outperform | RBC Capital Markets | |
11.01.24 | Richemont Buy | Goldman Sachs Group Inc. | |
11.01.24 | Richemont Overweight | JP Morgan Chase & Co. | |
11.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
11.01.24 | Givaudan Underperform | Jefferies & Company Inc. | |
10.01.24 | Swiss Re Sector Perform | RBC Capital Markets | |
10.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
10.01.24 | Nestlé Overweight | JP Morgan Chase & Co. | |
10.01.24 | Holcim Neutral | Merrill Lynch & Co., Inc. | |
10.01.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
10.01.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
10.01.24 | Givaudan Market-Perform | Bernstein Research | |
10.01.24 | ams-OSRAM Equal Weight | Barclays Capital | |
09.01.24 | ABB Hold | Jefferies & Company Inc. | |
09.01.24 | Roche Equal Weight | Barclays Capital | |
09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
09.01.24 | Givaudan Market-Perform | Bernstein Research | |
08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
08.01.24 | Novartis Neutral | UBS AG | |
08.01.24 | Richemont Sector Perform | RBC Capital Markets | |
08.01.24 | DocMorris Equal-weight | Morgan Stanley | |
05.01.24 | UBS Outperform | RBC Capital Markets |